These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 10553825)

  • 1. Renin angiotensin system antagonists and anesthesia.
    Colson P; Ryckwaert F; Coriat P
    Anesth Analg; 1999 Nov; 89(5):1143-55. PubMed ID: 10553825
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tissue angiotensin II and its impact in the treatment of arterial hypertension].
    Escobar-Morreale HF; González Albarrán O; García Robles R
    Med Clin (Barc); 1997 Jan; 108(3):105-8. PubMed ID: 9064431
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs targeting the renin-angiotensin-aldosterone system.
    Zaman MA; Oparil S; Calhoun DA
    Nat Rev Drug Discov; 2002 Aug; 1(8):621-36. PubMed ID: 12402502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The renin-angiotensin system and blood pressure regulation].
    Mann J
    Dtsch Med Wochenschr; 1994 Jul; 119(27):965-6. PubMed ID: 8026312
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin II receptor blockers: current perspective.
    Agrawal V; Manohar G; Kasliwal RR
    J Assoc Physicians India; 2003 Jul; 51():706-13. PubMed ID: 14621043
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor blockade in diabetic nephropathy.
    Andersen S
    Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
    [No Abstract]   [Full Text] [Related]  

  • 8. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiotensin-converting enzyme inhibitors: effects on renal physiology and applications in hypertension and renal disease].
    Cofán F; Romero R
    Rev Clin Esp; 1993 Jan; 192(1):31-8. PubMed ID: 8465029
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
    Costantino S; Millozzi F; Scarlata S
    Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Lyle PA; Tershakovec AM; Devereux RB; Oparil S; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Wedel H
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):729-45. PubMed ID: 16262560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
    Leary AC; MacDonald TM
    Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: observations from Val-HeFT and CALM.
    Chin BS; Lip GY
    J Hum Hypertens; 2001 Feb; 15(2):89-92. PubMed ID: 11317186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M
    Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotection with angiotensin type-1 receptor blockers in hypertension.
    Narain VS; Kochar A
    Indian Heart J; 2000; 52(1):89-92. PubMed ID: 10820943
    [No Abstract]   [Full Text] [Related]  

  • 17. [Alternative pathways of angiotensin I. The glimpse of new possibilities in the treatment of hypertension and heart failure].
    Francischetti EA
    Arq Bras Cardiol; 1995 Mar; 64(3):191-4. PubMed ID: 7487502
    [No Abstract]   [Full Text] [Related]  

  • 18. Kidney angiotensin receptors and their role in renal pathophysiology.
    Sandberg K; Ji H
    Semin Nephrol; 2000 Sep; 20(5):402-16. PubMed ID: 11022892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin II receptor antagonists].
    Chung O; Unger T
    Internist (Berl); 1996 May; 37(5):534-8; discussion 538. PubMed ID: 9011557
    [No Abstract]   [Full Text] [Related]  

  • 20. Renin-angiotensin system inhibitors as antihypertrophic agents.
    Ianosi-Irimie M; Deutsch P
    Pharmazie; 2000 Aug; 55(8):629. PubMed ID: 10989849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.